Earnings Labs
Halozyme Therapeutics, Inc. logo

Halozyme Therapeutics, Inc. (HALO) Earnings

NASDAQ·Healthcare·Biotechnology

$63.70

-1.23%

Mkt Cap $8.10B

Next Earnings

In 6 days

Tue, May 5, 2026

EPS Estimate

$1.54

4 analysts

Revenue Estimate

$358.56M

Last quarter: missed by -111.16% on EPS, +3.69% on revenue.

EPS — Estimate vs Actual

Mkt Cap

$8.10B

P/E

25.86

Fwd P/E

7.47

P/S

5.80

Rev TTM

EPS TTM

$2.49